Genomic landscape and prognosis of patients with <i>TP53</i>-mutated non-small cell lung cancer.

Ann Transl Med · 2022 · PMC8908146 · PMID 35280362

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Also, the EAp53 high-risk group showed a trend toward prolonged OS compared with the EAp53 low-risk group.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

Despite the similar DFS rates, patients in this study with stage I–III LUAD carrying a TP53 -MUT had worse OS than those carrying the TP53 -WT, although this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.